Nplate® Pregnancy Exposure Registry (NPER)
Nplate® Pregnancy Exposure Registry (NPER)
Sponsor: Amgen
Terminated
This trial was terminated. No reason was provided.
This observational or N/A phase trial investigates Birth Defect and Low Birth Weight and is currently terminated or withdrawn. Amgen leads this study, which shows 10 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2023 — Jul 2024 [monthly]
Terminated
-
Dec 2022 — Jan 2023 [monthly]
Terminated
-
Dec 2021 — Dec 2022 [monthly]
Terminated
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amgen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.